ClinicalTrials.Veeva

Menu

Renal Resistive Index as a Predictor of Renal Involvement in Rheumatoid Arthritis

A

Assiut University

Status

Not yet enrolling

Conditions

Rheumatoid Arthritis

Treatments

Diagnostic Test: KDIGO criteria of 2010

Study type

Observational

Funder types

Other

Identifiers

NCT06227442
PORIIRA

Details and patient eligibility

About

Evaluation of resistive index on the renal artery as early predictor factor of renal affection in patients with rheumatoid arthritis.

Full description

Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by synovial hyperplasia and inflammation, progressive joint destruction, and significant disability (1). It can occur at any age, but it predominantly affects women, with a peak onset between the ages of 40 and 60. RA etiology is not yet clear, Recent studies have shown that its mechanism is closely related to genetics, environment, and immune response. Genes such as MHC and HLA-DR4 are involved in the occurrence of RA. (2) Renal complications in RA can range from mild abnormalities in kidney function to more severe conditions, such as glomerulonephritis and renal amyloidosis. Understanding these renal complications is crucial for healthcare providers to ensure comprehensive care for RA patients. (3.4) Vasculitis is an uncommon complication of RA (in approximately 2 to 5% of patients), males with RA are more likely (2 to 4 times more likely) than females with RA to develop RV. Rheumatoid vasculitis most often occur in people with at least 10 years of severe disease. Fortunately, recent reports have noted declines in the prevalence of RV ( 5.6). So The renal arterial resistive index (RI)which is a sonographic index of intrarenal arteries defined as (peak systolic velocity - end-diastolic velocity) / peak systolic velocity. The normal range is 0.50-0.70. Elevated values are associated with poorer prognosis in various renal disorders .

Enrollment

144 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients of rheumatoid arthritis è renal affection
  • Patients of rheumatoid arthritis without renal affection
  • Patients of rheumatoid arthritis on drugs (NSAIDs, DMARDS, methotrexate..).

Exclusion criteria

  • Diabetic and hypertensive patients, patients with hepatitis B, C viruses or liver cell failure, patients with acute kidney injury, patients with another autoimmune disease as (SLE, sjogren disease, multiple sclerosis, patients with malignancy, patients on another drugs otherwise rheumatoid arthritis drugs).

Trial design

144 participants in 3 patient groups

Group A
Description:
will include 48 RA patients without renal affection.
Treatment:
Diagnostic Test: KDIGO criteria of 2010
Group B
Description:
will include 48 RA patients with renal affection.
Treatment:
Diagnostic Test: KDIGO criteria of 2010
Group C
Description:
will include 48 healthy control.
Treatment:
Diagnostic Test: KDIGO criteria of 2010

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems